Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase NA 2Phase 3 2Phase 2 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroblastoma 5Osteosarcoma 4Prostatic Neoplasms 3Multiple Myeloma 3Breast Neoplasms 3With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Neuroectodermal Tumors, Primitive 1Neoplasms, Plasma Cell 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1Chondrosarcoma 1CLDN18.2-positive Gastric Adenocarcinoma 1Bone Diseases 1Adenocarcinoma 1

Interventions

pembrolizumab 82Paclitaxel 71Gemcitabine 66Carboplatin 61Cisplatin 46Docetaxel 44Bevacizumab 41Nivolumab 33Irinotecan 31Fluorouracil 29Pemetrexed 28Cyclophosphamide 26Cetuximab 26Capecitabine 26Erlotinib Hydrochloride 22venetoclax 21trametinib 21Leucovorin 20Sorafenib 17Albumin-Bound Paclitaxel 17Afatinib 17130-nm albumin-bound paclitaxel 17Topotecan 16Radiotherapy 16Oxaliplatin 16fludarabine 15regorafenib 14budigalimab 14atezolizumab 14Ipilimumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neoplasms × Zoledronic Acid × Clear all
NCT01404702 2014-12-02

Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma

University of Alabama at Birmingham

Phase 1 Terminated
4 enrolled
CNS

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡